2025 Q4 -tulosraportti
Vain PDF
105 päivää sitten
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·5 t sitten · MuokattuWho put the tenner on @Bibikiki?
·7 t sittenSTOP THINKING OF CIRCIO AS A BIOTECH. THINK OF IT AS A SOFTWARE COMPANY. 💻🧬 This is the mindset shift that makes the whole case make sense. Typical biotech = one product, one disease, one bet. Either the medicine works, or the company dies. Binary. Circio is not built like that. circVec is not a medicine — it's an **operating system** for gene expression. 🖥️ Think of it literally: 🔹 Modular — same core, plugs into different programs 🔹 Runs on any "hardware" — AAV, LNP, viruses, cells 🔹 Comes in versions that get better every year — 2.1 → 3.0 → 3.2 → 4.0 🔄 🔹 Licensed out to others who build their own products on top of it But here's an important nuance Erik himself has been clear about: 👇 Don't get too hung up on the version numbers. The current generation is more than good enough. The point now is not to chase yet another upgrade — it's about proving that the technology actually works where it counts: in disease models, in vivo, against real targets. It's a mature signal. They have an engine that is strong enough. Now it's all about validation, not fine-tuning. 🎯 And that's why partners are lining up. They are not buying a product — they are licensing an engine. Across heart, eye, CNS, CAR-T, secretion. Many revenue streams, not one. 🏭 Honestly: still preclinical, nothing proven in humans yet. 📉 But the framework shouldn't be "yet another risky biotech". It should be "a platform in the hottest field in medicine — which is now moving from building to proving". You don't own a lottery ticket. You own the operating system. 🧱 We know what we own. ♟️🧱🍷
Same here, it will be fantastic the day we crack the cancer code, because holy hell a lot of misery it has created for families. Hope that they manage it and I will not sell a share until they reach the goal.
·8 t sittenWhile CRNA swung a pathetic 4 %, the forum mood went from "we're going to the moon, buy Eli Lilly and hire Elon" to "sell everything, mortgage the house, we're done" in 11 minutes flat. Someone in here has higher beta than a memecoin on a full moon. I suggest that the Oslo Stock Exchange lists the forum as its own ticker with 24/7 trading. It is far more entertaining, more liquid, and has clearer overbought/oversold signals than the stock itself. Regards from someone who is calmly holding the shares, eating popcorn and considering shorting the forum..
Yeah but I think we have the most active forum on Nordnet, It would have been boring without it.- ·8 t sittenBennyz is always right. Simply because what is written is one long stream of clichés and bombastic self-help phrases à la Get rich in one, two, three. All Bennyz' posts can easily be summarized as follows: SHAKING IN THE TREE IS PART OF THE JOURNEY. 🌳 Red today. But fear not — the tree is being shaken. Impatient hands fall out, the patient ones pick up. The floor holds. The roots stand. The fundamentals are strong. De-risking continues. 🧱 The price goes down, but that is actually positive. The price goes up, and that is of course also positive. Sentiment. Momentum. Fundamentals. Patience. Strong hands. Shaking. Roots. One can almost write an entire stock market post without saying anything at all. But one thing we know: We know what we own. ♟️🧱🍷Whether it's Bennyz or it's AI who is "the pen" is absolutely indifferent to me, as long as the content is substance and fact-based. I believe it clearly is in the way it is presented. I fully trust Erik Wiklund and the team around him. Therefore, Bennyz's post makes sense in my understanding, hence great support for him. As mentioned earlier, I have significant shares at a low average price. I have never sold a single share in Circio, only bought. This is my fact-based basis for investment here. So Big Pharma can knock politely on the door if they want the shares, but it will cost 💰💰📈
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
Vain PDF
105 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·5 t sitten · MuokattuWho put the tenner on @Bibikiki?
- ·7 t sittenSTOP THINKING OF CIRCIO AS A BIOTECH. THINK OF IT AS A SOFTWARE COMPANY. 💻🧬 This is the mindset shift that makes the whole case make sense. Typical biotech = one product, one disease, one bet. Either the medicine works, or the company dies. Binary. Circio is not built like that. circVec is not a medicine — it's an **operating system** for gene expression. 🖥️ Think of it literally: 🔹 Modular — same core, plugs into different programs 🔹 Runs on any "hardware" — AAV, LNP, viruses, cells 🔹 Comes in versions that get better every year — 2.1 → 3.0 → 3.2 → 4.0 🔄 🔹 Licensed out to others who build their own products on top of it But here's an important nuance Erik himself has been clear about: 👇 Don't get too hung up on the version numbers. The current generation is more than good enough. The point now is not to chase yet another upgrade — it's about proving that the technology actually works where it counts: in disease models, in vivo, against real targets. It's a mature signal. They have an engine that is strong enough. Now it's all about validation, not fine-tuning. 🎯 And that's why partners are lining up. They are not buying a product — they are licensing an engine. Across heart, eye, CNS, CAR-T, secretion. Many revenue streams, not one. 🏭 Honestly: still preclinical, nothing proven in humans yet. 📉 But the framework shouldn't be "yet another risky biotech". It should be "a platform in the hottest field in medicine — which is now moving from building to proving". You don't own a lottery ticket. You own the operating system. 🧱 We know what we own. ♟️🧱🍷Same here, it will be fantastic the day we crack the cancer code, because holy hell a lot of misery it has created for families. Hope that they manage it and I will not sell a share until they reach the goal.
- ·8 t sittenWhile CRNA swung a pathetic 4 %, the forum mood went from "we're going to the moon, buy Eli Lilly and hire Elon" to "sell everything, mortgage the house, we're done" in 11 minutes flat. Someone in here has higher beta than a memecoin on a full moon. I suggest that the Oslo Stock Exchange lists the forum as its own ticker with 24/7 trading. It is far more entertaining, more liquid, and has clearer overbought/oversold signals than the stock itself. Regards from someone who is calmly holding the shares, eating popcorn and considering shorting the forum..Yeah but I think we have the most active forum on Nordnet, It would have been boring without it.
- ·8 t sittenBennyz is always right. Simply because what is written is one long stream of clichés and bombastic self-help phrases à la Get rich in one, two, three. All Bennyz' posts can easily be summarized as follows: SHAKING IN THE TREE IS PART OF THE JOURNEY. 🌳 Red today. But fear not — the tree is being shaken. Impatient hands fall out, the patient ones pick up. The floor holds. The roots stand. The fundamentals are strong. De-risking continues. 🧱 The price goes down, but that is actually positive. The price goes up, and that is of course also positive. Sentiment. Momentum. Fundamentals. Patience. Strong hands. Shaking. Roots. One can almost write an entire stock market post without saying anything at all. But one thing we know: We know what we own. ♟️🧱🍷Whether it's Bennyz or it's AI who is "the pen" is absolutely indifferent to me, as long as the content is substance and fact-based. I believe it clearly is in the way it is presented. I fully trust Erik Wiklund and the team around him. Therefore, Bennyz's post makes sense in my understanding, hence great support for him. As mentioned earlier, I have significant shares at a low average price. I have never sold a single share in Circio, only bought. This is my fact-based basis for investment here. So Big Pharma can knock politely on the door if they want the shares, but it will cost 💰💰📈
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
2025 Q4 -tulosraportti
Vain PDF
105 päivää sitten
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 31.8. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 15.4. | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2024 Q4 -tulosraportti 10.4.2025 | ||
2024 Q2 -tulosraportti 29.8.2024 | ||
2023 Q4 -tulosraportti 25.4.2024 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·5 t sitten · MuokattuWho put the tenner on @Bibikiki?
- ·7 t sittenSTOP THINKING OF CIRCIO AS A BIOTECH. THINK OF IT AS A SOFTWARE COMPANY. 💻🧬 This is the mindset shift that makes the whole case make sense. Typical biotech = one product, one disease, one bet. Either the medicine works, or the company dies. Binary. Circio is not built like that. circVec is not a medicine — it's an **operating system** for gene expression. 🖥️ Think of it literally: 🔹 Modular — same core, plugs into different programs 🔹 Runs on any "hardware" — AAV, LNP, viruses, cells 🔹 Comes in versions that get better every year — 2.1 → 3.0 → 3.2 → 4.0 🔄 🔹 Licensed out to others who build their own products on top of it But here's an important nuance Erik himself has been clear about: 👇 Don't get too hung up on the version numbers. The current generation is more than good enough. The point now is not to chase yet another upgrade — it's about proving that the technology actually works where it counts: in disease models, in vivo, against real targets. It's a mature signal. They have an engine that is strong enough. Now it's all about validation, not fine-tuning. 🎯 And that's why partners are lining up. They are not buying a product — they are licensing an engine. Across heart, eye, CNS, CAR-T, secretion. Many revenue streams, not one. 🏭 Honestly: still preclinical, nothing proven in humans yet. 📉 But the framework shouldn't be "yet another risky biotech". It should be "a platform in the hottest field in medicine — which is now moving from building to proving". You don't own a lottery ticket. You own the operating system. 🧱 We know what we own. ♟️🧱🍷Same here, it will be fantastic the day we crack the cancer code, because holy hell a lot of misery it has created for families. Hope that they manage it and I will not sell a share until they reach the goal.
- ·8 t sittenWhile CRNA swung a pathetic 4 %, the forum mood went from "we're going to the moon, buy Eli Lilly and hire Elon" to "sell everything, mortgage the house, we're done" in 11 minutes flat. Someone in here has higher beta than a memecoin on a full moon. I suggest that the Oslo Stock Exchange lists the forum as its own ticker with 24/7 trading. It is far more entertaining, more liquid, and has clearer overbought/oversold signals than the stock itself. Regards from someone who is calmly holding the shares, eating popcorn and considering shorting the forum..Yeah but I think we have the most active forum on Nordnet, It would have been boring without it.
- ·8 t sittenBennyz is always right. Simply because what is written is one long stream of clichés and bombastic self-help phrases à la Get rich in one, two, three. All Bennyz' posts can easily be summarized as follows: SHAKING IN THE TREE IS PART OF THE JOURNEY. 🌳 Red today. But fear not — the tree is being shaken. Impatient hands fall out, the patient ones pick up. The floor holds. The roots stand. The fundamentals are strong. De-risking continues. 🧱 The price goes down, but that is actually positive. The price goes up, and that is of course also positive. Sentiment. Momentum. Fundamentals. Patience. Strong hands. Shaking. Roots. One can almost write an entire stock market post without saying anything at all. But one thing we know: We know what we own. ♟️🧱🍷Whether it's Bennyz or it's AI who is "the pen" is absolutely indifferent to me, as long as the content is substance and fact-based. I believe it clearly is in the way it is presented. I fully trust Erik Wiklund and the team around him. Therefore, Bennyz's post makes sense in my understanding, hence great support for him. As mentioned earlier, I have significant shares at a low average price. I have never sold a single share in Circio, only bought. This is my fact-based basis for investment here. So Big Pharma can knock politely on the door if they want the shares, but it will cost 💰💰📈
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt